We included all studies (observational or clinical trials) comparing PD-1 or PD-L1 either with each other or with chemotherapy in patients with ES-SCLC. We included studies that enrolled patients aged 18 years or more. The gene discussed is CD274; the disease is small cell lung carcinoma.